Patent · US Active

Pyrazolyl quinoxaline kinase inhibitors

US8895601B2 · kind B2 · utility

23Cited by
8References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2011
Grant dateNov 25, 2014
Priority date—
Expiry dateApr 28, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6524
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.